COVID-19 vaccine safety
| Autor: | Nataniel Aldo Chaparro Mérida, Dayany Moreno Samper, Alex Omar Franco Lacato |
|---|---|
| Jazyk: | Spanish; Castilian |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Revista Peruana de Medicina Experimental y Salud Pública, Vol 38, Iss 4, Pp 634-42 (2021) |
| Druh dokumentu: | article |
| ISSN: | 1726-4634 1726-4642 |
| DOI: | 10.17843/rpmesp.2021.384.9308 |
| Popis: | The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic. Adverse events following immunization are unwanted responses or unintended events that must be carefully monitored, as all vaccines, including those developed against SARS-CoV-2, are required to meet safety criteria for administration in humans. Information was collected from the PubMed/Medline database during the months of August 2020 to November 2021. Most adverse events reported in clinical trials were mild or moderate; however, thrombotic events associated with some viral vector-based vaccines against COVID-19 were identified in follow-up studies, although completion of the various ongoing studies and post-marketing surveillance is required to determine all potential adverse events, as well as those of special interest. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|